USD 5.01 billion
Report ID: SQMG35D2016 | Region: Global | Published Date: October, 2022 | Pages: 157
Global Orthobiologics Market was valued at USD 5.01 billion in 2021, and it is expected to reach a value of USD 6.91 billion by 2028, at a CAGR of 4.7% over the forecast period (2022-2028).
The rise in the frequency of sports injuries and traffic accidents are two important factors anticipated to propel the growth of the orthobiologics market during the forecast period. It is projected that the market for orthobiologics would grow as a result of the rise in spinal diseases and disorders. It is also predicted that the growing patient desire for minimally invasive procedures will restrain the expansion of the orthobiologics market. However, the rise in the price of orthobiologics-based treatments may restrain the market's expansion throughout the forecast period. The market for orthobiologics is expanding at an accelerated rate due to the rise in the elderly and obese population.
Regenerative cellular therapies are another name for orthobiologics. Orthobiologic products contain growth factors that improve and stimulate discomfort, promote tissue healing, and aid in restoring normal function.
Global Market Size
USD 5.01 billion
To get more reports on the above market click here to Buy The Report
The Global Orthobiologics Market is segmented based on Product, Application, End-use and Region. Based on the Product, the Global Orthobiologics Market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes & Stem Cell Therapy. Based on the Application, the Global Orthobiologics Market is segmented into Spinal Fusion, Trauma Repair, Maxillofacial & Dental& Reconstructive Surgery. Based on End-Use, it is segmented into Hospitals, Ambulatory Surgical Centers& Orthopedic Clinics. Based on Region, it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Analysis by Product
Viscosupplementation commanded the lion's share of the orthobiologics market in the product segment in 2015. The significant proportion is related to the widespread availability and extraordinary adoption of these medicines in conditions including osteoarthritis and hip degenerative joint degeneration. The advantages of viscosupplementation are thought to be the cause of the high adoption rate. These advantages include improved knee mobility, pain relief, reduced invasiveness, and fewer adverse effects. It is also assumed that this is due to the great demand for minimally invasive surgical treatments and the high acceptability of these techniques by the patient population.
Analysis by Application
Over 50.0% of the application segment's market share was accounted for by spinal fusion. Demineralized bone matrices, bone morphogenetic proteins, autografts, and allografts have consistently gained a dominant share in spinal fusion surgery due to their capacity to deliver high bone stability and quick bone healing while alleviating long-term spinal diseases. A bigger proportion in the application segment is thought to be the result of other advantages of orthobiological products in spinal fusion, such as quick activation of cells to commence bone growth and reduced hospital stay time and visits. The significant market shares that orthobiologics has gained is also seen to be a result of the existence of third-party insurers and the availability of reimbursement for fusion augmentation devices, which has led to growth.
Analysis by End Use
The end-use segment was dominated by hospitals. One important element contributing to the market share dominance is the growing use of orthobiological products in a variety of spinal and reconstructive procedures carried out in hospitals. In addition, it is projected that hospitals' easy access to a large variety of orthobiologics and their specialized patient care will contribute to the segment's expansion.
Additionally, frequent readmissions, significant patient turnover, and high procedure volumes all contributed to the category share. Additionally, the supportive infrastructure makes precise operating procedures possible, which is expected to significantly increase the growth potential.
To get detailed analysis on other segments, Request For Sample Report
Orthopedic Surgery in outpatient settings is increasing, favoring the North American Market. North America's market is estimated to rule the industry for the entire forecast year. The market in North America may see growth between 2019 and 2026 as a result of the business strategies of top American manufacturers, benevolent reimbursement policies, rising prevalence of degenerative bone diseases, and rising trend of orthopaedic procedures in outpatient settings. Due to the recent marketing approval for Cingal, a viscosupplement, in Europe, Europe is anticipated to be the second most lucrative region with a sizable market share..
Due to the rising demand for viscosupplements in India and the growing number of independent orthopaedic clinics, Asia Pacific is anticipated to have the highest CAGR throughout the projection period. Due to the increased need for the treatment of sports injuries and a rise in government initiatives to raise awareness of orthobiologics, Latin America and the Middle East & Africa are anticipated to have a significant market potential during the projection period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
One of the main issues affecting the elderly population is knee osteoarthritis, which is extensively treated with viscosupplements. Hyaluronic acid injections known as viscosupplements are given right into the joints. High product costs, new manufacturer entrants, and recent marketing approvals are the major variables linked to the expansion of viscosupplements segments. Additionally, the viscosupplements segments are benefiting from better reimbursement policies. Given the aforementioned aspects, it is projected that the increased demand for viscosupplements will propel the growth of the worldwide orthobiologics market during the forecast period.
It is projected that the market for orthobiologics would grow as a result of the rise in spinal diseases and disorders. Additionally, the frequency of traffic accidents is also predicted to increase the market.
It is predicted that the growing patient desire for minimally invasive procedures will restrain the expansion of the orthobiologics market. The market for orthobiologics may face additional difficulties in the near future due to the negative effects of Bmp-based therapy.
It is also estimated that the rise in the price of orthobiologics-based treatments may restrain the market's expansion throughout the forecast period. The market is constrained by complex synthesis procedures, manufacturing regulations, and high production prices. Orthobiologics goods and treatments have high costs and insufficient reimbursements, which are additional key issues limiting this market's growth. One of the major obstacles to the expansion of the global orthobiologics market is the high cost of orthobiologics treatments and products.
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Medtronic has become the market leader because of the excellent introduction and quick uptake of infuse bone morphogenetic protein. Medtronic is anticipated to hold the largest share during the forecast period due to infuse's higher price, strong sales team, and April 2018 FDA clearance for use in a new indication for spine surgery. Musculoskeletal Transplant Foundation, Zimmer Biomet, Wright Medical Group N.V., DePuy Synthes (Johnson & Johnson Services, Inc.), Stryker, Sea Spine, Bioventus, RTI Surgical Holdings, Inc. and Anika Therapeutics, Inc. are additional companies that compete on the international market.
Top Player's Company Profiles
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our Global Orthobiologics Market Analysis, the major segment of the global orthobiologics market, viscosupplements segment is projected to expand in forecasted period owing to high product costs, new manufacturer entrants, and recent marketing approvals. Furthermore, increased incidence of diseases and disorders like spinal diseases and traffic accidents will also increase the demand of the market in the forecasted area.
|Market size value in 2021||USD 5.01 billion|
|Market size value in 2028||USD 6.91 billion|
|Forecast Unit (Value)||USD Billion|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Orthobiologics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Orthobiologics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Orthobiologics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Orthobiologics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.SPEAK TO AN ANALYST
Get lifetime access to our reportsBasic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOW
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.
Product ID: SQMG35D2016